- Home
- TASK vs ENOV Comparison
TASK vs ENOV Comparison
Compare TASK & ENOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TASK
- ENOV
- Stock Information
- Founded
- TASK 2008
- ENOV 1995
- Country
- TASK United States
- ENOV United States
- Employees
- TASK N/A
- ENOV N/A
- Industry
- TASK Retail: Computer Software & Peripheral Equipment
- ENOV Fluid Controls
- Sector
- TASK Technology
- ENOV Industrials
- Exchange
- TASK Nasdaq
- ENOV Nasdaq
- Market Cap
- TASK 1.5B
- ENOV 1.6B
- IPO Year
- TASK 2021
- ENOV 2008
- Fundamental
- Price
- TASK $17.39
- ENOV $31.02
- Analyst Decision
- TASK Buy
- ENOV Strong Buy
- Analyst Count
- TASK 5
- ENOV 6
- Target Price
- TASK $17.40
- ENOV $51.00
- AVG Volume (30 Days)
- TASK 234.9K
- ENOV 1.1M
- Earning Date
- TASK 08-07-2025
- ENOV 08-07-2025
- Dividend Yield
- TASK N/A
- ENOV N/A
- EPS Growth
- TASK 21.25
- ENOV N/A
- EPS
- TASK 0.67
- ENOV N/A
- Revenue
- TASK $1,101,465,000.00
- ENOV $2,189,576,000.00
- Revenue This Year
- TASK $19.40
- ENOV $8.23
- Revenue Next Year
- TASK $11.62
- ENOV $6.18
- P/E Ratio
- TASK $25.96
- ENOV N/A
- Revenue Growth
- TASK 19.04
- ENOV 14.40
- 52 Week Low
- TASK $10.57
- ENOV $25.47
- 52 Week High
- TASK $19.60
- ENOV $49.83
- Technical
- Relative Strength Index (RSI)
- TASK 61.31
- ENOV 58.00
- Support Level
- TASK $17.19
- ENOV $29.37
- Resistance Level
- TASK $17.66
- ENOV $32.03
- Average True Range (ATR)
- TASK 0.19
- ENOV 1.14
- MACD
- TASK 0.02
- ENOV 0.41
- Stochastic Oscillator
- TASK 61.65
- ENOV 74.94
About TASK TaskUs Inc.
TaskUs Inc is a provider of outsourced digital services and next-generation customer experience to the world's most innovative companies, helping its clients represent, protect and grow their brands. It serves clients in the fastest-growing sectors, including social media, e-commerce, gaming, streaming media, food delivery and ridesharing, HiTech, FinTech and HealthTech.
About ENOV Enovis Corporation
Enovis Corp is a medical technology company that offers medical devices and services across the continuum of patient care, from injury prevention to joint replacement to rehabilitation after surgery, injury, or degenerative disease. Its reportable segments are Prevention & Recovery (P&R) and Reconstructive (Recon). The company generates the maximum revenue from the Prevention & Recovery segment, which includes products that are used to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports-related injuries. The Reconstructive segment provides a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and surgical productivity tools. Geographically, it derives key revenue from the U.S.